As scientists continue to unlock the molecular mysteries of aging, 5-Amino-1MQ stands out as a research target that requires more human safety and efficacy data in the quest for a healthier, longer life
Semaglutide, the former, is still in the research phase
Since there is no known hazardous threshold for vitamin B12, there is no upper limit
As we age, though, our bodies can begin to lose the ability to absorb vitamins effectively
Duration of Study: Short-term acute studies (e.g., 24-48 hours) will naturally have a different 5-Amino-1MQ dosage profile than long-term chronic studies (e.g., 4-12 weeks)
Consult with a healthcare provider You can visit a primary care provider, walk-in clinic, or telehealth platform that offers lab review